相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers
Lara A. Dunn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association
R. Michael Tuttle et al.
THYROID (2019)
Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck Ultrasound
Giorgio Grani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine- refractory differentiated thyroid cancer
Makoto Tahara et al.
EUROPEAN JOURNAL OF CANCER (2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial
Hakim-Moulay Dehbi et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Interobserver agreement of various thyroid imaging reporting and data systems
Giorgio Grani et al.
ENDOCRINE CONNECTIONS (2018)
Selective RET kinase inhibition for patients with RET-altered cancers
V. Subbiah et al.
ANNALS OF ONCOLOGY (2018)
Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence
David T. Hughes et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Analytical Performance of the ThyroSeq v3 Genomic Classifier for Cancer Diagnosis in Thyroid Nodules
Marina N. Nikiforova et al.
CANCER (2018)
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
Jaume Capdevila et al.
CANCER TREATMENT REVIEWS (2018)
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev et al.
CLINICAL CANCER RESEARCH (2018)
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
Y. Ito et al.
EJSO (2018)
A Phase 2 Trial of Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Carcinoma in the First-Line Setting
M. S. Brose et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Kutluk Oktay et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
A. Drilon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance
Akira Miyauchi et al.
SURGERY (2018)
Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice
Amandine Berdelou et al.
THYROID (2018)
Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis
Lawrence Chen et al.
WORLD JOURNAL OF SURGERY (2018)
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Catharina Balmelli et al.
JOURNAL OF CANCER (2018)
Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan
Iwao Sugitani et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2018)
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies
F. Pacini et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial
Martin Schlumberger et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Giorgio Grani et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Efficacy of Vandetanib in Treating Locally Advanced or Metastatic Medullary Thyroid Carcinoma According to RECIST Criteria: A Systematic Review and Meta-Analysis
Pierpaolo Trimboli et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with anaplastic thyroid cancer.
Lori J. Wirth et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A randomized doubled blind phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients (pts) with differentiated thyroid carcinoma (DTC) progressing after first line therapy: EORTC 1209.
Martin Schlumberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
G. Mazziotti et al.
ENDOCRINE (2018)
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base
Todd A. Pezzi et al.
CANCER (2017)
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer
Marie Terroir et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012
Seung-Kuk Baek et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Desiree Deandreis et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
L. Dal Maso et al.
EUROPEAN JOURNAL OF CANCER (2017)
Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff
Ana Reyes Romero-Lluch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Systematic review of site distribution of bone metastases in differentiated thyroid cancer
Marcela Osorio et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Screening for Thyroid Cancer US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study
Palak Choksi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial
Maria E. Cabanillas et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial
Marcia S. Brose et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Efficacy of postoperative radiation treatment for bone metastases in the extremities
Leah Drost et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon et al.
THYROID (2017)
Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy
Suyeon Park et al.
THYROID (2017)
Leveraging the immune system to treat advanced thyroid cancers
Jena D. French et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Lenvatinib for Anaplastic Thyroid Cancer
Makoto Tahara et al.
FRONTIERS IN ONCOLOGY (2017)
Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer
Julien Hadoux et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Radioembolisation of hepatocellular carcinoma: a primer
N. Venkatanarasimha et al.
CLINICAL RADIOLOGY (2017)
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis
Huy Gia Vuong et al.
CLINICAL ENDOCRINOLOGY (2017)
Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis
Wan-jun Zhao et al.
EJSO (2017)
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
M. Schlumberger et al.
ANNALS OF ONCOLOGY (2017)
ESMO-Magnitude of Clinical Benefit Scale version 1.1
N. I. Cherny et al.
ANNALS OF ONCOLOGY (2017)
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence
Tihana Ibrahimpasic et al.
CLINICAL CANCER RESEARCH (2017)
Tumor Volume Doubling Time of Pulmonary Metastases Predicts Overall Survival and Can Guide the Initiation of Multikinase Inhibitor Therapy in Patients With Metastatic, Follicular Cell-Derived Thyroid Carcinoma
Mona M. Sabra et al.
CANCER (2017)
Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes
Robert I. Haddad et al.
ENDOCRINE (2017)
Percutaneous osteosynthesis in the pelvis in cancer patients
Frederic Deschamps et al.
EUROPEAN RADIOLOGY (2016)
The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis
Jeanny Kwon et al.
EUROPEAN JOURNAL OF CANCER (2016)
Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach
Livia Lamartina et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Cytological features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features and their correlation with tumor histology
Francesca Maletta et al.
HUMAN PATHOLOGY (2016)
Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer
Livia Lamartina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
Denise P. Momesso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer
Bruce Robinson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines
A. L. Mitchell et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2016)
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations
Cristina Romei et al.
JOURNAL OF MEDICAL GENETICS (2016)
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
Marcia S. Brose et al.
LANCET ONCOLOGY (2016)
The changing incidence of thyroid cancer
Cari M. Kitahara et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Salvatore Vaccarella et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Management of advanced medullary thyroid cancer
Julien Hadoux et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
Yuri E. Nikiforov et al.
JAMA ONCOLOGY (2016)
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer
Lars Bastholt et al.
EUROPEAN THYROID JOURNAL (2016)
Drug induced osteonecrosis of the jaw
Issam S. Hamadeh et al.
CANCER TREATMENT REVIEWS (2015)
Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012
Aubrey A. Carhill et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
Livia Lamartina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
South Korea's Thyroid-Cancer Epidemic - Turning the Tide
Hyeong Sik Ahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Postoperative Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: An Important Imaging Modality in Patients with Aggressive Histology of Differentiated Thyroid Cancer
Camila Nascimento et al.
THYROID (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Gerald S. Falchook et al.
THYROID (2015)
Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art
T. de Baere et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2015)
Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival An Analysis of 61,775 Patients
Mohamed Abdelgadir Adam et al.
ANNALS OF SURGERY (2014)
Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience
A. Mohebati et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Total Thyroidectomy is Associated with Increased Risk of Complications for Low- and High-Volume Surgeons
Adam Hauch et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Treatment of Advanced Thyroid Cancer With Axitinib: Phase 2 Study With Pharmacokinetic/Pharmacodynamic and Quality-of-Life Assessments
Laura D. Locati et al.
CANCER (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
DIAGNOSIS OF ENDOCRINE DISEASE Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper
Luca Giovanella et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Thyroglobulin in Lymph Node Fine-Needle Aspiration Washout: A Systematic Review and Meta-analysis of Diagnostic Accuracy
Giorgio Grani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Randomized Safety and Efficacy Study of Fosbretabulin with Paclitaxel/Carboplatin Against Anaplastic Thyroid Carcinoma
Julie A. Sosa et al.
THYROID (2014)
In Search of an Unstimulated Thyroglobulin Baseline Value in Low-Risk Papillary Thyroid Carcinoma Patients Not Receiving Radioactive Iodine Ablation
Trevor E. Angell et al.
THYROID (2014)
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
Martin Schlumberger et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Percutaneous ablation of bone tumors
F. Deschamps et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2014)
Prophylactic central neck dissection for papillary thyroid cancer
M. Barczynski et al.
BRITISH JOURNAL OF SURGERY (2013)
Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
Elizabeth Fox et al.
CLINICAL CANCER RESEARCH (2013)
Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS
Nishant Agrawal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Alan L. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid Cancer
L. Leenhardt et al.
EUROPEAN THYROID JOURNAL (2013)
Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumors
Ken-ichi Ito et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?
Cosimo Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
Sophie Leboulleux et al.
LANCET ONCOLOGY (2012)
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer
R. Elisei et al.
EUROPEAN THYROID JOURNAL (2012)
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
D. Deandreis et al.
ENDOCRINE-RELATED CANCER (2011)
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
Maria Grazia Castagna et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients
M. Brassard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Approach to the Thyroid Cancer Patient with Bone Metastases
Jason A. Wexler
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
Carole A. Spencer
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The Surgical Management of Goiter: Part II. Surgical Treatment and Results
Gregory W. Randolph et al.
LARYNGOSCOPE (2011)
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review
Eric J. Sherman et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
Robert L. Foote et al.
THYROID (2011)
Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
Akira Miyauchi et al.
THYROID (2011)
Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
Govardhanan Nagaiah et al.
JOURNAL OF ONCOLOGY (2011)
Papillary Thyroid Carcinoma With Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma. A Clinicopathologic, Immunohistochemical, and Molecular Study of Eight Cases
Sofia Asioli et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation
Laurie L. Carr et al.
CLINICAL CANCER RESEARCH (2010)
Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis
Johannes A. A. Meijer et al.
CLINICAL ENDOCRINOLOGY (2010)
Does Postoperative Thyrotropin Suppression Therapy Truly Decrease Recurrence in Papillary Thyroid Carcinoma? A Randomized Controlled Trial
Iwao Sugitani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas
Cosimo Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer
Andreas Machens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
Keith C. Bible et al.
LANCET ONCOLOGY (2010)
Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
R. Michael Tuttle et al.
THYROID (2010)
The Bethesda System for Reporting Thyroid Cytopathology
Edmund S. Cibas et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer Long-term Results of a Phase 2 Clinical Trial
Fabienne Iten et al.
CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR ANAPLASTIC THYROID CARCINOMA: TOXICITY AND SURVIVAL ANALYSIS
Prasad Dandekar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls
Giuseppe Costante et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2009)
The value of positron emission tomography (PET) in the management of patients with thyroid cancer
Richard J. Robbins et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Progression of medullary thyroid carcinoma:: assessment with calcitonin and carcinoembryonic antigen doubling times
Anne Laure Giraudet et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study
Ezra E. W. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Predictive Value of Recombinant Human TSH Stimulation and Neck Ultrasonography in Differentiated Thyroid Cancer Patients
Umberto Crocetti et al.
THYROID (2008)
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma
Trond Velde Bogsrud et al.
THYROID (2008)
Extent of surgery affects survival for papillary thyroid cancer
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2007)
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer
Sophie Leboulleux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Poorly differentiated thyroid carcinoma: The Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach
Marco Volante et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
Sophie Leboulleux et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules
Giuseppe Costante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens
Yongjin Wang et al.
CANCER (2006)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
RJ Robbins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma
J Barbet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas
L Bodei et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Follow-up of low risk patients with papillary thyroid cancer:: Role of neck ultrasonography in detecting lymph node metastases
M Torlontano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
R De Crevoisier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Effects of thyroid hormone suppression therapy on aciverse clinical outcomes in thyroia cancer
NJ McGriff et al.
ANNALS OF MEDICINE (2002)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion
KB Ain et al.
THYROID (2000)
分享论文
